Accès aux médicaments

Souscrire au flux RSS de cette rubrique

Histoire et composants dans cette catégorie

Article
17 August 2017
+ English - Cacher

Auteur: David Gelles, Landon Thomas Jr., Andrew Ross Sorkin & Kate Kellyaug, NY Times (USA)

On Tuesday, Indra Nooyi, the chief executive of PepsiCo, joined a call with other prominent corporate chieftains who...had agreed to advise...Trump. A rebellion was brewing. Along with other business leaders, [she]...watched with bafflement over the...

Lire la suite

Article
9 July 2017
+ English - Cacher

Auteur: Sarah Neville, Financial Times (UK)

The UK drugs industry is going to court in an attempt to stop the country’s taxpayer-funded National Health Service from imposing new limits on the price it will pay for medicines. The action follows a government crackdown in April that limits funding...

Lire la suite

Article
26 May 2017

Colombie : Novartis conteste devant la Cour suprême l'émission d’une déclaration d’intérêt public sur un anticancéreux ouvrant la voie à la production de génériques

Auteur: Ram Etwareea, Le Temps (Suisse)

« Novartis attaque la Colombie en justice », 23 mai 2017...

Lire la suite

Article
19 April 2017

Novartis accusé d’avoir menacé la Colombie de recourir à l’arbitrage pour éviter l'émission d'une licence obligatoire sur un anticancéreux ; avec les commentaires de l’entreprise

Auteur: Bilan (Suisse)

« Novartis accusé de pression sur la Colombie », 12 avril 2017...

Lire la suite

Article
12 April 2017
+ English - Cacher

Auteur: Public Eye

"Compulsory licensing in Colombia: Leaked documents show aggressive lobbying by Novartis", 11 Apr 2017...

Lire la suite

Article
6 February 2017
+ English - Cacher

Auteur: Damiano de Felice, Access to Medicines Index, on Harvard Business Review

"How Pharma Can Fix Its Reputation and Its Business at the Same Time", 3 Feb 2017...

Lire la suite

Article
31 January 2017
+ English - Cacher

Auteur: Lydia Ramsey, Business Insider (UK)

"The makers of insulin are being accused of price-fixing in a class-action lawsuit", 30 Jan 2017...

Lire la suite

Article
26 January 2017
+ Português - Cacher

Auteur: Grupo de Trabalho sobre Propriedade Intelectual-GTPI (Brazil)

“INPI rejeita pedido de patente do Truvada® no Brasil-Com a decisão, a combinação de medicamentos que atua na prevenção do HIV passa a fazer parte do domínio público”, 24 de janeiro de 2017...

Lire la suite

Histoire
17 January 2017
+ English - Cacher
Article
16 January 2017
+ English - Cacher

Auteur: Council of Europe & Uppsala University

The Committee on Bioethics (DH-BIO) published a study prepared at its request by researchers from Uppsala University Department of Law (Sweden) on the challenges posed to the rights of the child by scientific and technological developments in...

Lire la suite